TRPC6 is a Biomarker for Prognosis and Immunotherapy of Stomach Adenocarcinoma Based on Bioinformatic Analysis and Experimental Validation

TRPC6 is a Biomarker for Prognosis and Immunotherapy of Stomach Adenocarcinoma Based on Bioinformatic Analysis and Experimental Validation

Xingchi Hu,1,2 Hongwei Wang,1,2 Haitao Sun,3 Jingxin Zhang,3 ZhenXiong Ye,4 Zhenhua Huang3 1Department of General Surgery, Yancheng First Hospital, Affiliated Hospital of Nanjing University Medical School, Yancheng, Jiangsu, 224000, People’s Republic of China; 2Department of General Surgery, The Fir...

Full description

Saved in:
Bibliographic Details
Main Authors: Hu X, Wang H, Sun H, Zhang J, Ye Z, Huang Z
Format: Article
Language:English
Published: Dove Medical Press 2024-12-01
Series:ImmunoTargets and Therapy
Subjects:
trpc6
stomach adenocarcinoma
immunotherapy
biomarkers
Online Access:https://www.dovepress.com/trpc6-is-a-biomarker-for-prognosis-and-immunotherapy-of-stomach-adenoc-peer-reviewed-fulltext-article-ITT
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.dovepress.com/trpc6-is-a-biomarker-for-prognosis-and-immunotherapy-of-stomach-adenoc-peer-reviewed-fulltext-article-ITT

Similar Items